A single piece of dried blood could soon be enough for an AI-powered test capable of detecting pancreatic, gastric, and colorectal cancers. This new tool analyzes metabolites present in the blood, serving as biomarkers that indicate the presence of cancer. The test showed promising results in early trials, with 82-100% accuracy in distinguishing between cancer patients and healthy individuals.
Researchers have developed a new AI-powered test that can potentially diagnose three major types of cancer using only a single spot of dried blood. The test, which analyzes metabolites in blood samples, showed high accuracy in preliminary experiments, detecting cancer in 82% to 100% of cases. The tool could revolutionize cancer screening by providing a low-cost, accessible method for early detection. However, further testing and validation are needed before the test can be used in clinical practice.
